Genfit

GENFIT is a private drug discovery company based in Lille- France, focused on developing novel orally available drugs addressing cardiovascular, metabolic and inflammatory disorders.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Aging
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Dermatology
- Diabetes
- Genetics
- Infectious Diseases
- Obesity
- Stroke

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: Europe , Asia , North America

c. Countries active: France, Deutschland, Japan, USA

Corporate data:

Number of Employees: 80

Turnover:

Amount:	Year:	Currency:
9260000	2002	Euro

Year founded: 1999

Partners / Alliances: Genfit’s management team has an extensive drug research partnering experience with pharmaceutical companies, and has set a strong reporting organization and collaborative spirit towards synergy of skills between scientists.
Genfit has now twelve collaborative Programs with eight Pharma groups: Aventis, Pierre Fabre, Laboratoires Fournier, Kowa, Merck AG, Sanofi-Synthélabo, UCB Pharma and LFB, focused either on early stage new target-based strategies, or drug optimization and profiling.